Longitudinally monitored immune biomarkers predict the timing of COVID-19 outcomes.

Longitudinally monitored immune biomarkers predict the timing of COVID-19 outcomes.

The clinical outcome of SARS-CoV-2 infection varies widely between individuals. Machine learning models can support decision making in healthcare by assessing fatality risk in patients that do not yet show severe signs of COVID-19. Most predictive models rely on static demographic features and clini...

Full description

Bibliographic Details
Main Authors: Gorka Lasso, Saad Khan, Stephanie A Allen, Margarette Mariano, Catalina Florez, Erika P Orner, Jose A Quiroz, Gregory Quevedo, Aldo Massimi, Aditi Hegde, Ariel S Wirchnianski, Robert H Bortz, Ryan J Malonis, George I Georgiev, Karen Tong, Natalia G Herrera, Nicholas C Morano, Scott J Garforth, Avinash Malaviya, Ahmed Khokhar, Ethan Laudermilch, M Eugenia Dieterle, J Maximilian Fels, Denise Haslwanter, Rohit K Jangra, Jason Barnhill, Steven C Almo, Kartik Chandran, Jonathan R Lai, Libusha Kelly, Johanna P Daily, Olivia Vergnolle
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS Computational Biology
Online Access:https://doi.org/10.1371/journal.pcbi.1009778

Internet

https://doi.org/10.1371/journal.pcbi.1009778

Similar Items